نتایج جستجو برای: Hypo-fractionated

تعداد نتایج: 13784  

Journal: :Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2015
Georgios Koukourakis Georgios Zacharias Aristides Petridis

PURPOSE The aim of the current study was to evaluate the efficacy and tolerability of hypo-fractionated whole breast radiation therapy in patients with early breast cancer. METHODS Searching electronically PubMed and the Cochrane Central Register we made a comprehensive literature review regarding the randomized controlled phase III trials for hypo-fractionated radiation therapy in early brea...

Journal: :Physics in medicine and biology 2015
Hamidreza Badri Jagdish Ramakrishnan Kevin Leder

Metastasis is the process by which cells from a primary tumor disperse and form new tumors at distant anatomical locations. The treatment and prevention of metastatic cancer remains an extremely challenging problem. This work introduces a novel biologically motivated objective function to the radiation optimization community that takes into account metastatic risk instead of the status of the p...

2013
Andre Vera Henry Weatherburn Kamalendu Malaker

Presternal butterfly keloid management remains a clinical challenge. This case indicates, with hypo fractionated external beam electron therapy a significant symptomatic and cosmetic benefit may be achieved without any unacceptable acute, chronic or long term toxicity.

Journal: :International Journal of Radiation Oncology*Biology*Physics 2020

2016
Ayaka Sasaki Shinichiro Miyazaki Tomokatsu Hori

Facial nerve schwannoma is a rare intracranial tumor. Treatment for this benign tumor has been controversial. Here, we report a case of extracranial facial nerve schwannoma treated successfully by hypo-fractionated CyberKnife (Accuray, Sunnyvale, CA) radiosurgery and discuss the efficacy of this treatment. A 34-year-old female noticed a swelling in her right mastoid process. The lesion enlarged...

2016
Anja Derer Martina Spiljar Monika Bäumler Markus Hecht Rainer Fietkau Benjamin Frey Udo S. Gaipl

Immunotherapy approaches currently make their way into the clinics to improve the outcome of standard radiochemotherapy (RCT). The programed cell death receptor ligand 1 (PD-L1) is one possible target that, upon blockade, allows T cell-dependent antitumor immune responses to be executed. To date, it is unclear which RCT protocol and which fractionation scheme leads to increased PD-L1 expression...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید